COVID-19 (Coronavirus): Pharmacologic nuclear stress testing

July 15, 2021

This article was revised on July 15, 2021, to update the coverage position.

Effective July 15, 2021, Independence has resumed medical necessity reviews for new prior authorization requests for a pharmacologic stress test with nuclear imaging in lieu of exercise stress testing.​

AIM guidelines

For Independence plans that are subject to radiology utilization management through AIM Specialty Health® (AIM) for outpatient non-emergent diagnostic imaging services and certain high-technology radiology services, AIM will apply the above coverage criteria to determine the medical necessity for these services.

To view AIM’s current and future guidelines, go to the Resources section of AIM’s website.

Independence is committed to providing our members with access to the care they need during the COVID-19 pandemic. We encourage all Independence members and providers to visit our dedicated COVID-19 webpage regularly for the latest news and updates. We will continue to evaluate member needs as the situation changes.

Learn more

For information on the impacted policies and a list of eligible procedure codes, read the Medical and Claim Payment Policy News Articles: